Extracorporeal Life Support Organization Registry International Report 2016

  title={Extracorporeal Life Support Organization Registry International Report 2016},
  author={Ravi R. Thiagarajan and Ryan P. Barbaro and Peter T. Rycus and D Michael McMullan and Steven A. Conrad and J. Dennis Fortenberry and Matthew L. Paden},
  journal={ASAIO Journal},
Data on extracorporeal life support (ECLS) use and survival submitted to the Extracorporeal Life Support Organization’s data registry from the inception of the registry in 1989 through July 1, 2016, are summarized in this report. [] Key Result The registry contained information on 78,397 ECLS patients with 58% survival to hospital discharge. Extracorporeal life support use and centers providing ECLS have increased worldwide. Extracorporeal life support use in the support of adults with respiratory and…
Pediatric Extracorporeal Life Support Organization Registry International Report 2016
Adverse events including neurologic events were common during ECLS, a fact that underscores the opportunity and need to promote quality improvement work.
The Extracorporeal Life Support Organization Registry: update and perspectives.
The E LSO Registry is under substantial re-engineering which will allow and provide the ELSO members and the scientific community an enhanced scientific tool to elucidate various aspects of the ECLS settings, including trends and disease-specific information.
Highlights from the Extracorporeal Life Support Organization Registry: 2006-2017.
A brief summary of 16 publications in peer-reviewed journals using data from the ELSO registry and that have helped improve knowledge and care of neonates, children, and adults treated with ECMO.
Extracorporeal life support in adult patients with out-of-hospital cardiac arrest.
A rapid and organised approach is required for resuscitation, i.e. cannula insertion with ECMO pump initiation in combination with other aspects of post-cardiac arrest care such as targeted temperature management and early coronary reperfusion, as limited studies have reported on its cost-effectiveness.
Indications and outcomes of extracorporeal life support in trauma patients
Overall survival from ECLS was 70% and survival to hospital discharge was 61% in the total cohort, similar to survival rates in other ELSO registry cohorts, and trauma should not be considered a contraindication for ECLs.
Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19.
The use of ECLS for ARDS patients, trauma patients, cardiogenic shock patients, and post cardiac arrest patients are reviewed and how these principles are applied in the management of the novel coronavirus disease (COVID-19) pandemic is described.
Appraising extracorporeal life support - current and future roles in adult intensive care.
5 Despite advances in conventional intensive care, patients continue to die of cardiorespiratory failure. Many of them could be bridged to recovery, longer term destination devices or thoracic organ
Extracorporeal life support in cardiogenic shock: indications and management in current practice
Indications, daily clinical management and complications of VA-ECLS in cardiogenic shock refractory to conventional treatment strategies are discussed.
Outcomes of Adults with Congenital Heart Disease Supported with Extracorporeal Life Support After Cardiac Surgery.
Patients with adult congenital heart disease (ACHD) who undergo cardiac surgery may require extracorporeal life support (ECLS) for cardiopulmonary support, but outcomes after ECLS support have not


Extracorporeal Life Support Organization Registry Report 2012
Summary data from the annual international Extracorporeal Life Support Organization (ELSO) Registry Reports through July 2012 are presented, showing use of ECLS for cardiac support represents a large area of consistent growth.
Extracorporeal Life Support Registry Report 2008: Neonatal and Pediatric Cardiac Cases
From the data, it is evident that cardiac ECLS patients have a lower chance of survival than respiratory EclS patients, and furthermore, younger patients haveA lower chanceof survival.
Extracorporeal Life Support Organization 1994.
The annual report of the Extracorporeal Life Support Organization is presented for 1994 and rates of survival for each patient group remained unchanged from previous years with 81% neonatal, 50% pediatric, and 44% cardiac survival.
Extracorporeal Life Support Registry Report 1995.
The annual ELSO Registry Report for 1995 is presented, and the survival rate is gradually improving in pediatric and adult respiratory cases.
Extracorporeal Life Support Organization 1993.
This is the annual report of the Extracorporeal Life Support Organization. It concerns the aggregate experience of all reported patients treated with extracorporeal membrane oxygenation as of April
Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.
In this international, case-mix-adjusted analysis, higher annual hospital ECMO volume was associated with lower mortality in 1989-2013 for neonates and adults; the association among adults persisted in 2008-2013.
Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality*
Although the survival of pediatric patients with acute respiratory failure treated with extracorporeal membrane oxygenation has not changed, this treatment is currently offered to increasingly medically complex patients.
Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: Are there differences in survival and acute complications?
Overall survival of pediatric patients with acute respiratory failure supported by VA or VV ECLS was comparable, and a randomized clinical trial may be useful in clarifying these observations.
Factors Associated With Mortality in Neonates Requiring Extracorporeal Membrane Oxygenation for Cardiac Indications: Analysis of the Extracorporeal Life Support Organization Registry Data*
  • M. FordK. Gauvreau R. Thiagarajan
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2016
Objectives: Survival among neonates supported with extracorporeal membrane oxygenation for cardiac indications is 39%. Previous single-center studies have identified factors associated with